Bhutan vs Ecuador: HIV-positive TB patients on ART (antiretroviral therapy)
Bhutan
100.0%
in 2024
Ecuador
100.0%
in 2024
Bhutan rank
1st
Ecuador rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bhutan
- Ecuador
How they compare
Bhutan currently reports 100.0% against 100.0% in Ecuador, a difference of 0.0%.
The two have swapped places 8 times across 14 shared years of data; in 2008 it was Ecuador ahead.
Bhutan ranks 1st and Ecuador ranks 1st of 144 countries.
Across the 3 decades both report, Bhutan averaged higher in 1 and Ecuador in 1.
Head to head by decade
| Decade | Bhutan | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 100.0% | 0.0% | — |
| 2010s | 92.9% | 94.6% | 1.7% | Ecuador |
| 2020s | 100.0% | 93.8% | 6.2% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bhutan or Ecuador?
- Bhutan, at 100.0% against 100.0% in Ecuador as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bhutan and Ecuador?
- 0.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Ecuador?
- 14 years are reported by both, from 2008 to 2024.
- How do Bhutan and Ecuador rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bhutan ranks 1st and Ecuador ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.